摘要
To investigate the role of neutrophils and neutrophil extracellular traps (NETs) in obesity-exacerbated allergic asthma, and to evaluate the therapeutic potential of targeting this pathway.
Diet-induced obese mice (high-fat diet) and genetically obese ob/ob mice were used to establish allergic asthma models induced by house dust mite (HDM) or ovalbumin (OVA). Csf3 knockout (Csf3⁻/⁻) mice were employed to deplete neutrophils, and Padi4 knockout (Padi4⁻/⁻) mice were used to specifically block NETosis while preserving neutrophil counts. Anti-Ly6G antibody and the PAD4 inhibitor Cl-amidine were administered as pharmacological interventions. Airway hyperresponsiveness (AHR), inflammatory cell counts in bronchoalveolar lavage fluid (BALF), cytokine levels (IL-6, TNF-α, IL-17A), NETs quantification, lung histopathology, and RNA sequencing of bone marrow neutrophils were evaluated.
Obese asthmatic mice exhibited significantly increased total inflammatory cells and neutrophils in BALF, aggravated AHR, enhanced peribronchial inflammation, and elevated levels of IL-6, TNF-α, NETs, and IL-17A. In Csf3⁻/⁻ obese asthmatic mice, airway inflammation, mucus hypersecretion, cytokine release, and NETs were markedly attenuated, with improved lung function, indicating that neutrophils are both necessary and sufficient for obesity-exacerbated asthma. RNA sequencing revealed upregulation of NETosis-related genes in bone marrow neutrophils from obese asthmatic mice, with significant enrichment of the NET formation pathway by KEGG analysis. In vitro experiments confirmed that BALF from obese asthmatic mice directly induced greater NET release from normal neutrophils. In Padi4⁻/⁻ obese asthmatic mice, which have normal neutrophil counts but defective NET formation, airway inflammation, AHR, mucus secretion, and inflammatory cytokines were all significantly reduced, similar to the effects of neutrophil depletion. In ob/ob mice, pharmacological inhibition of NETosis with Cl-amidine also effectively ameliorated all asthma-related pathologies.
The neutrophil-NETosis axis is a central pathogenic driver of obesity-exacerbated asthma, and PAD4-dependent NET formation is the critical effector mechanism independent of neutrophil infiltration itself. Targeting this pathway significantly alleviates airway inflammation and improves lung function, providing a novel therapeutic target for obesity-related refractory asthma.
